Litcius/Paper detail

Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial

Douglas R. Adkins, Jessica Ley, Omar Atiq, Steven Powell, William C. Spanos, Mark M. Gitau, Caron Rigden, Kevin Palka, Jingxia Liu, Peter Oppelt

2021Oral Oncology29 citationsDOIOpen Access PDF

Topics & Concepts

CetuximabMedicineCarboplatinRegimenInternal medicineOncologyHead and neck squamous-cell carcinomaPaclitaxelHead and neck cancerProgression-free survivalRadiation therapyCancerChemotherapyColorectal cancerCisplatinHead and Neck Cancer StudiesPeptidase Inhibition and AnalysisBrain Metastases and Treatment
Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial | Litcius